Ken Griffin Zimmer Biomet Holdings, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$119.98 - $132.61 $3.08 Million - $3.41 Million	-25,700 Reduced 12.31%	183,100 $24.2 Million
Q4 2023 Feb 14, 2024	SELL	$102.72 - $121.7 $20.5 Million - $24.3 Million	-199,700 Reduced 48.89%	208,800 $25.4 Million
Q3 2023 Nov 14, 2023	BUY	$110.76 - $143.18 $36.7 Million - $47.4 Million	331,300 Added 429.15%	408,500 $45.8 Million
Q2 2023 Aug 14, 2023	BUY	$126.43 - $145.6 $7.35 Million - $8.46 Million	58,100 Added 304.19%	77,200 $11.2 Million
Q1 2023 May 15, 2023	SELL	$121.91 - $130.94 $3.11 Million - $3.34 Million	-25,500 Reduced 57.17%	19,100 $2.47 Million

Q4 2022 Feb 14, 2023	SELL	$104.7 - $128.4 $41,880 - $51,360	-400 Reduced 0.89%	44,600 $5.69 Million
Q3 2022 Nov 14, 2022	BUY	$101.65 - $119.27 $1.93 Million - $2.27 Million	19,000 Added 73.08%	45,000 $4.71 Million

1,086

181M

474K

687K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.3B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.